OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES

Autor: AR Fonseca, CC Justino, VC Molla, PE Yamakawa, IB Rabelo, A Hill, L Arnold, R Kelly, M Griffin, T Munir, E Velloso, T Dalessandro, AM Risitano, P Scheinberg, A Kulasekararaj, C Arrais-Rodrigues

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S17- (2023)

This multicenter international retrospective analysis aimed to evaluate the efficacy and safety of subcutaneous alemtuzumab (ALZ) as an alternative immunosuppressive therapy for aplastic anemia (AA). The study included 57 with AA patients who receive

Externí odkaz: https://doaj.org/article/9019b3e2c3ce41f898c65193ae4a950e

Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study.

Autor: Duffles G; Rede Dor Sao Luiz, Sao Paulo, Brazil.; University of Campinas, Hematology and Hemotherapy Centre, Sao Paulo, Brazil., Braga A; Hematology, AC Camargo Cancer Center, Sao Paulo, Brazil., Silveira T; Hematology, AC Camargo Cancer Center, Sao Paulo, Brazil., Novis Y; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Arrais C; Unifesp, Sao Paulo, Brazil., Tucunduva L; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Fonseca AR; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Borducchi D; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Centro Universitário da Faculdade de medicina do ABC, Sao Paulo, Brazil., Neffa P; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Instituto do câncer do estado de São Paulo, ICESP, Sao Paulo, Brazil., Blumm F; Rede Dor Sao Luiz, Sao Paulo, Brazil., Gonçalves MC; Hematology, Hospital Sirio-Libanes, Sao Paulo, Brazil., Moreira F; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil., Nucci F; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Hospital universitário Antônio Pedro, Universidade Federal Fluminense, UFF, Niterói, Rio de Janeiro, Brazil., Rego E; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil.; Instituto Dor de pesquisa e Ensino, IDOR, Sao Paulo, Brazil., Rocha V; Rede Dor Sao Luiz, Sao Paulo, Brazil.; Department of Hematology, Hemotherapy & Cell Therapy, Faculty of Medicine, University of São Paulo (FMUSP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of São Paulo (USP), Sao Paulo, SP, Brazil.; Churchill Hospital, Oxford University, Oxford, United Kingdom.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep 10, pp. 1-7. Date of Electronic Publication: 2024 Sep 10.

The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review.

Autor: Dorf SR; Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil., Fonseca AR; Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil., Sztajnbok FR; Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil., Oliveira TRD; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil., Basttistella LR; Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brasil.

Publikováno v: Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo [Rev Paul Pediatr] 2024 Mar 25; Vol. 42, pp. e2023093. Date of Electronic Publication: 2024 Mar 25 (Print Publication: 2024).

Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review.

Autor: Nagem Lopes LP; Post-Graduate Program in Pharmaceutical Sciences, University of Sorocaba, São Paulo, Brazil., da Cunha LG; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Silva ARO; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Land MGP; Post-Graduate Program in Saúde Materno Infantil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Fonseca AR; Post-Graduate Program in Saúde Materno Infantil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Lopes LC; Post-Graduate Program in Pharmaceutical Sciences, University of Sorocaba, São Paulo, Brazil., Lima EC; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2023 Aug 23; Vol. 14, pp. 1228986. Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023).

Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study.

Autor: Sestan M; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia., Kifer N; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia., Sozeri B; University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey., Demir F; University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey., Ulu K; University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey., Silva CA; Pediatric Rheumatology Unit, ICr-HC-FMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Campos RT; Pediatric Rheumatology Unit, ICr-HC-FMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Batu ED; Department of Pediatrics, Hacettepe University, Ankara, Turkey., Koker O; Department of Pediatric Rheumatology, Marmara University-Pendik Training and Research Hospital, Istanbul, Turkey., Sapina M; Department of Paediatrics, Josip Juraj Strossmayer University of Osijek, Medical Faculty and Faculty of Dental Medicine and Health Osijek, University Hospital Centre Osijek, Osijek, Croatia., Srsen S; Department of Paediatrics, University of Split School of Medicine, University Hospital Centre Split, Split, Croatia., Held M; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia., Gagro A; Department of Paediatrics, Children's Hospital Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia; Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Osijek, Croatia., Fonseca AR; Universidade Federal do Rio de Janeiro, Instituto de Puericultura e Pediatria Martagão Gesteira, Rio de Janeiro, Brazil., Rodrigues M; Universidade Federal do Rio de Janeiro, Instituto de Puericultura e Pediatria Martagão Gesteira, Rio de Janeiro, Brazil., Rigante D; Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica Sacro Cuore, Rome, Italy., Filocamo G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Baldo F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Heshin-Bekenstein M; Pediatric Rheumatology Service, Dana Dwek Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel., Giani T; AOU Meyer, Florence, Italy., Kataja J; Department of Paediatrics and Adolescents Medicine, Turku University Hospital, Turku, Finland., Frkovic M; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia., Ruperto N; IRCCS Istituto Giannina Gaslini, UOSID centro trial, Genoa, Italy., Ozen S; Department of Pediatrics, Hacettepe University, Ankara, Turkey., Jelusic M; Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia. Electronic address: marija.jelusic@mef.hr.

Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2023 Aug; Vol. 61, pp. 152209. Date of Electronic Publication: 2023 Apr 26.